Abacus Health Products Inc. (fka ABCS)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

MustBeTheTruth Free

02/19/20 8:33 AM

Post #8

7 Cannabis Stocks With New Analyst Ratings and Price Targets

click here! Great read

Chrism0000 Free

08/29/19 10:44 AM

Post #6

Tried looking them up do they trade yet or under diff name at this time?

Penny Masters Free

08/27/19 1:01 PM

Post #5

Rob Gronkowski signs with this company and that is big for the CBD industry.

https://finance.yahoo.com/news/rob-gronkowski-becomes-advocate-cbd-143400507.html

morokoy

05/03/19 12:07 AM

Post #4

Mentioned in article.
https://www.forbes.com/sites/alanjbrochstein/2019/03/10/investing-in-cbd-stocks-offers-opportunity-but-risks/#4aa84cf0bc42

CBD_

04/30/19 10:45 PM

Post #3

https://www.newswire.ca/news-releases/abacus-health-products-announces-full-year-2018-results-821045868.html

Revenue of Abacus U.S. for the full year 2018 was $8.5 million, an increase of 232% over the same 12-month period in 2017.

CBDMEDIC™, sold to consumers via retail chains and its e-commerce platform, launched towards the end of 2018 and added new advanced skincare and treatment products to the line in 2019.

First CBDMEDIC™ purchase order from a major U.S. retail chain was announced in February 2019 with new purchase orders received in April 2019.

Revenue of Abacus U.S. for the fourth quarter 2018 was $2.9 million representing sequential growth of 43% over the prior quarter.

Gross profit of Abacus U.S. for the year ended December 31, 2018 was approximately $5.1 million representing a gross margin of 59.2%, an increase from 51.5% for the year ended 2017.